These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 9076585

  • 1. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S.
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [Abstract] [Full Text] [Related]

  • 2. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
    Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S.
    J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
    [Abstract] [Full Text] [Related]

  • 3. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 4. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL, Casinghino S, Centrella M, Canalis E.
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [Abstract] [Full Text] [Related]

  • 5. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK, Kiefer MC, Riggs BL, Conover CA.
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [Abstract] [Full Text] [Related]

  • 6. Secretion of insulin-like growth factor (IGF)-I and -II and IGF binding proteins (IGFBPs) in fetal stromal-vascular (S-V) cell cultures obtained before and after the onset of adipogenesis in vivo.
    Hausman GJ, Richardson RL, Simmen FA.
    Growth Dev Aging; 2002 Jan; 66(1):11-26. PubMed ID: 12212627
    [Abstract] [Full Text] [Related]

  • 7. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH).
    Fottner C, Engelhardt D, Weber MM.
    Horm Metab Res; 1999 Jan; 31(2-3):203-8. PubMed ID: 10226803
    [Abstract] [Full Text] [Related]

  • 8. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M, Okazaki R, De León D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL.
    Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO, Chen BK, Bale LK, Overgaard MT, Oxvig C, Conover CA.
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [Abstract] [Full Text] [Related]

  • 10. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG, Morgan J, Schwander J, Bleehen NM.
    Cancer Res; 1993 Oct 01; 53(19):4680-5. PubMed ID: 7691401
    [Abstract] [Full Text] [Related]

  • 11. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
    Foulstone EJ, Savage PB, Crown AL, Holly JM, Stewart CE.
    J Cell Physiol; 2003 Apr 01; 195(1):70-9. PubMed ID: 12599210
    [Abstract] [Full Text] [Related]

  • 12. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul 01; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 13. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
    Qin X, Byun D, Lau KH, Baylink DJ, Mohan S.
    Arch Biochem Biophys; 2000 Jul 15; 379(2):209-16. PubMed ID: 10898936
    [Abstract] [Full Text] [Related]

  • 14. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL, Cohen P.
    Growth Horm IGF Res; 1999 Aug 15; 9(4):241-53. PubMed ID: 10512690
    [Abstract] [Full Text] [Related]

  • 15. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
    Rutter MM, Markoff E, Clayton L, Akeno N, Zhao G, Clemens TL, Chernausek SD.
    Bone; 2005 Feb 15; 36(2):224-31. PubMed ID: 15780948
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical localization of insulin-like growth factor binding protein-1, -3 and -4 in human fetal tissues and their analysis in media from fetal tissue explants.
    Braulke T, Götz W, Claussen M.
    Growth Regul; 1996 Jun 15; 6(2):55-65. PubMed ID: 8781981
    [Abstract] [Full Text] [Related]

  • 17. Autocrine regulators of MC3T3-E1 cell proliferation.
    Amarnani S, Merriman HL, Linkhart TA, Baylink DJ, Mohan S.
    J Bone Miner Res; 1993 Feb 15; 8(2):157-65. PubMed ID: 7680184
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA, Moats-Staats BM, Stiles AD.
    Am J Respir Cell Mol Biol; 1995 Oct 15; 13(4):466-76. PubMed ID: 7546777
    [Abstract] [Full Text] [Related]

  • 19. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
    Barjot C, Navarro M, Cotten ML, Garandel V, Bernardi H, Bacou F, Barenton B.
    J Cell Physiol; 1996 Nov 15; 169(2):227-34. PubMed ID: 8908189
    [Abstract] [Full Text] [Related]

  • 20. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L, Fauconnet S, Lamielle F, Adessi GL.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 15; 46(7):1173-82. PubMed ID: 11075947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.